GS
PRTK

GTS Securities’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

GTS Securities’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,000
Closed -$48.6K – 4194
2023
Q2 		$48.6K Buy
+22,000
New +$45.6K ﹤0.01% 1131

GTS Securities's PRTK Position: Q3 2023 in Review

GTS Securities sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 22,000 shares — an estimated $48.6K sold.

GTS Securities first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $48.6K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

  • GTS Securities reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • GTS Securities sold 22,000 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $48.6K.
  • GTS Securities first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
  • GTS Securities's Paratek Pharmaceuticals, Inc. position peaked at $48.6K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on GTS Securities's 13F filing for Q3 2023, filed 15 Nov 2023.